May 23, 2017
The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania's Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.